Do you want to skip to content? Skip to content
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Convatec

Most visited pages

Reports, results and presentations
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

Convatec Group Plc (“Convatec”), a global medical products and technologies company, today welcomes the publication of an international expert panel consensus addressing the challenge of biofilm to improve outcomes in hard-to-heal wounds.1

Despite biofilm being widely documented and understood to be the main cause of delayed healing in hard-to-heal wounds, many healthcare practitioners still wait for overt signs of infection, delayed healing or other complications before intervening. Convatec brought together an international group of leading wound care practitioners who devised the concept of Wound Hygiene; a simple 4-step regime which is based on the premise that just as we follow basic, essential, repetitive hygiene activities every day by washing our hands, brushing our teeth and showering, so should we apply basic hygiene to wounds.2 Wound Hygiene has now been fully described as a core, non-negotiable component of wound care that comprises cleansing of the wound and periwound, wound debridement, refashioning of the wound edges and application of an antimicrobial dressing; and can be safely undertaken by both specialist and generalist healthcare practitioners in any setting.1

“It is clear that the wound care puzzle is missing a piece.” says Christine Murphy, PhD, RN, WOC(C), The Ottawa Hospital Limb Preservation Centre and Chair of the International Wound Hygiene Panel. “Evidence is mounting that this piece is biofilm management, which is increasingly recognised as a factor in a multitude of chronic disease conditions. Therefore, it may be time to rethink what ‘best practice’ entails, particularly in wounds that are colonised by biofilm or infected.”

“The increasing number of hard-to-heal wounds and associated antibiotic usage are a huge concern for the healthcare system.” said David Shepherd, President and COO, Global Advanced Wound Care at Convatec. “We welcome the introduction of Wound Hygiene as it was developed by experts to help all wound care practitioners address the challenge of biofilm by better preparing wounds for healing and making appropriate product choices in to reduce infection rates, accelerate healing and improve patient outcomes in hard-to-heal-wounds.”

To learn more about Wound Hygiene please visit  www.woundhygiene.com

 

  1. Murphy C, Atkin L, Swanson T, Tachi M, Tan YK, Vega de Ceniga M, Weir D, Wolcott R. International consensus document. Defying hard-to-heal wounds with an early antibiofilm intervention strategy: wound hygiene. J Wound Care 2020;29(Suppl 3b):S1-28

  2. Murphy C, Atkin L, Dissemond J, Hurlow J, Tan YK, Apelqvist J, James G, Salles N, Wu J, Tachi M, Wolcott R. Defying hard-to-heal wounds with an early antibiofilm intervention strategy: “wound hygiene.” J Wound Care 2019;28:818–22

 

For more information please call:  Charles Ryland/Chris Lane/Vicky Hayns at Buchanan +44 (0)207 466 5000

 

About Convatec

Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.

Press Release

See all

5/13/2022

5/13/2022

Convatec announces the release of ConvaMax™

Convatec announces the release of ConvaMax™

Read more

5/13/2022

5/13/2022

Interim Results for the 6 months ended 30 June 2020

Interim Results for the 6 months ended 30 June 2020

Read more

5/13/2022

5/13/2022

Trading update for the three months ended 30 September 2020

Trading update for the three months ended 30 September 2020

Read more

5/13/2022

5/13/2022

Expert panel publishes Wound Hygiene consensus

Expert panel publishes Wound Hygiene consensus

Read more

5/13/2022

5/13/2022

Non-Executive Director appointment

Non-Executive Director appointment

Read more

5/13/2022

5/13/2022

Convatec Group Plc Annual Results 2019

Convatec Group Plc Annual Results 2019

Read more

5/13/2022

5/13/2022

Trading update for the three months ended 31 March 2020

Trading update for the three months ended 31 March 2020

Read more

5/13/2022

5/13/2022

Non-Executive Director appointment

Non-Executive Director appointment

Read more

5/13/2022

5/13/2022

Board Changes

Board Changes

Read more

5/13/2022

5/13/2022

Non-Executive Director appointment

Non-Executive Director appointment

Read more